B. Kocak Et Al. , "Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports," TRANSPLANTATION PROCEEDINGS , vol.45, no.3, pp.1022-1025, 2013
Kocak, B. Et Al. 2013. Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports. TRANSPLANTATION PROCEEDINGS , vol.45, no.3 , 1022-1025.
Kocak, B., Arpali, E., Demiralp, E., Yelken, B., Karatas, C., Gorcin, S., ... Gorgulu, N.(2013). Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports. TRANSPLANTATION PROCEEDINGS , vol.45, no.3, 1022-1025.
Kocak, B. Et Al. "Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports," TRANSPLANTATION PROCEEDINGS , vol.45, no.3, 1022-1025, 2013
Kocak, B. Et Al. "Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports." TRANSPLANTATION PROCEEDINGS , vol.45, no.3, pp.1022-1025, 2013
Kocak, B. Et Al. (2013) . "Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports." TRANSPLANTATION PROCEEDINGS , vol.45, no.3, pp.1022-1025.
@article{article, author={B. Kocak Et Al. }, title={Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports}, journal={TRANSPLANTATION PROCEEDINGS}, year=2013, pages={1022-1025} }